PREMARKET ALERT: Cubist Pharmaceuticals (CBST)

Posted in General 
July 17th, 2009

Cubist Pharmaceuticals Inc. (Nasdaq: CBST) shares rose more than 3 percent to $17.90 after hours. The company beat EPS expectations by 12 cents a share, reported in-line revenue that rose nearly 29 percent from the same period a year earlier. and reaffirmed guidance for fiscal 2009. — Mike Tarsala

Comments are closed